(MENAFN- EIN Presswire) EINPresswire/ -- Emerald, a UK-based preventive health platform, has released a new analysis of over 25,000 comprehensive biomarker tests, revealing that early warning signs of ...
Importantly, a previous subgroup analysis of the EMERALD PFS results, which were presented at the San Antonio Breast Cancer Symposium (SABCS) 2022, demonstrated that the duration of prior CDK4/6i ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results